Clinical and biochemical studies in mucopolysaccharidosis type II carriers

Journal of Inherited Metabolic Disease

Volumn 32, Issue 6, 2009, Pages 732-738

  Schwartz, I V D ^a,b   Pinto, L L C ^a,b   Breda, G ^b   Lima, L ^b   Ribeiro, M G ^c   Mota, J G ^d   Acosta, A X ^e   Correia, P ^f   Horovitz, D D G ^f   Porciuncula, C G G ^g   Lipinski Figueiredo, E ^g   Fett Conte, A C ^h   Oliveira Sobrinho, R P ⁱ   Norato, D Y J ⁱ   Paula, A C ^j   Kim, C A ^j   Duarte, A R ^k   Boy, R ^l   Leistner Segal, S ^b   Burin, M G ^b   Giugliani, R ^a,b   more..

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Institute of Oncology of the South of Minas Gerais (ISMO)   (Brazil)

^e FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^h FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

ⁱ UNIVERSITY OF CAMPINAS   (Brazil)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

^k INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^l STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; IDURONATE 2 SULFATASE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BIOCHEMISTRY; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUMAN CELL; HUNTER SYNDROME; LEUKOCYTE; MAJOR CLINICAL STUDY; PEDIGREE ANALYSIS; PHYSICAL EXAMINATION; REFERENCE VALUE; URINALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FAMILY; FAMILY HEALTH; FEMALE; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUCOPOLYSACCHARIDOSIS II; PEDIGREE; PHYSICAL EXAMINATION; YOUNG ADULT;

EID: 76949102597     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1275-9     Document Type: Article

References (52)

1. D Applegarth JR Toone RB Lowry 2000 Incidence of inborn errors of metabolism in British Columbia, 1969-1996 Pediatrics 105 1 6 10.1542/peds.105.1.e10
2. IM Archer PS Harper FS Wusteman 1981 An improved assay for iduronate 2-sulphatase in serum and its use in the detection of carriers of the Hunter syndrome Clin Chim Acta 112 107 112 10.1016/0009-8981(81)90274-6 1:CAS:528:DyaL3MXkt1Shs7o%3D 6786801 (Pubitemid 11096128)
3. IM Archer ID Young DW Rees, et al. 1983 Carrier detection in Hunter syndrome Am J Med Genet 16 61 69 10.1002/ajmg.1320160111 1:STN:280: DyaL2c%2FkvFGgtw%3D%3D 6227239
4. F Baehner C Schmiedeskamp F Krummenauer, et al. 2005 Cumulative incidence rates of the mucopolysaccharidoses in Germany J Inherit Metab Dis 28 1011 1017 10.1007/s10545-005-0112-z 1:STN:280:DC%2BD28%2FksF2rsw%3D%3D 16435194 (Pubitemid 43168938)
5. DM Broadhead JM Kirk AJ Burt, et al. 1986 Full expression of Hunters disease in a female with an X-chromosome deletion leading to non-random inactivation Clin Genet 30 392 398 1:STN:280:DyaL2s7gtlOjsA%3D%3D 3100113
6. M Capobianchi G Romeo 1976 Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome Experientia 32 459 460 10.1007/BF01920795 1:CAS:528:DyaE28XhslOrsLs%3D 817929
7. JTR Clarke HF Willard I Teshima, et al. 1990 Hunter disease (mucopolysaccharidose type II) in a karyotipically normal girl Clin Genet 37 355 362 1:STN:280:DyaK3c3osVSrsA%3D%3D 2112988
8. JTR Clarke PJ Wilson CP Morris, et al. 1993 Reply to Migeon Am J Hum Genet 52 433 434
9. S Cudry I Tigaud R Froissart, et al. 2000 MPS II in females: molecular basis of two different cases J Med Genet 37 E29 10.1136/jmg.37.10.e29 1:STN:280:DC%2BD3cvmslCitQ%3D%3D 11015461
10. BS Danes AG Bearn 1965 Hurler's syndrome: demonstration of an inherited disorder of connective tissue in cell culture Science 149 987 989 10.1126/science.149.3687.987 1:STN:280:DyaF28%2FgsVejtQ%3D%3D 4953285
11. JGN de Jong RA Wevers R Liebrand-van Sambeek 1992 Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue Clin Chem 38 803 807 1597005
12. PB Deegan AF Baehner MA Barba Romero, et al. 2006 Natural history of Fabry disease in females in the Fabry Outcome Survey J Med Genet 43 347 352 10.1136/jmg.2005.036327 1:CAS:528:DC%2BD28Xktlymtbg%3D 16227523
13. RJ Desnick KY Allen S Desnick, et al. 1973 Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes J Lab Clin Med 81 157 170 1:STN:280:DyaE3s%2FnsVeisg%3D%3D 4683418
14. Desnick RJ, Ioannoy YA, Eng C (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 7th edn. McGraw-Hill, New York, pp 3733-3774
15. WB Dobyns A Filauro BN Tomson, et al. 2004 Inheritance of most X-linked traits is not dominant or recessive, just X-linked Am J Med Genet A 129A 2 136 143 10.1002/ajmg.a.30123 15316978
16. P Donnelly N Di Ferrante 1975 Reliability of the Booth-Nadet technique for the detection of Hunter heterozygotes Pediatrics 56 429 433 1:STN:280:DyaE28%2FhtFGkug%3D%3D 808791
17. R Froissart I Maire V Bonnet, et al. 1997 Germline and somatic mosaicism in a female carrier of Hunter disease J Med Genet 34 137 140 10.1136/jmg.34.2.137 1:STN:280:DyaK2s7pt1WksA%3D%3D 9039991
18. MP Gallegos-Arreola MV Machorro-Lazo SE Flores-Martínez, et al. 2000 Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses Arch Med Res 31 505 510 10.1016/S0188-4409(00)00104-1 1:CAS:528:DC%2BD3MXhsFWqtro%3D 11179586 (Pubitemid 32114182)
19. I Hozumi M Nishizawa T Ariga, et al. 1990 Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry's disease) in comparison with hemizygotes J Lipid Res 31 335 340 1:CAS:528:DyaK3cXhslKntLg%3D 2157788
20. C Kampmann F Baehner M Ries, et al. 2002 Cardiac involvement in Anderson-Fabry disease J Am Soc Nephrol 13 S147 149 12068028
21. C Kampmann F Baehner C Whybra, et al. 2002 Cardiac involvement of Anderson-Fabry disease in heterozygous females J Am Coll Cardiol 40 1668 1674 10.1016/S0735-1097(02)02380-X 12427421 (Pubitemid 35253646)
22. Larking PW, McDonald BW, Taylor ML, Kirkland AD (1987) Urine glycosaminoglycans in a reference population: effects of age, body surface area, and postmenopausal status 37:246-254
23. SP Lin JH Chang GJ Lee-Chen, et al. 2006 Detection of Hunter syndrome (mucopolysaccharidosis type II) in Tawanese: biochemical and linkage studies of iduronate-2-sulfatase gene defects in MPS II patients and carriers Clin Chim Acta 369 29 34 10.1016/j.cca.2006.01.001 1:CAS:528:DC%2BD28Xlt1CmtLo%3D 16480701 (Pubitemid 43783398)
24. HY Lin SP Lin CK Chuang, et al. 2009 Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004 Am J Med Genet A 149A 960 964 10.1002/ajmg.a.32781 19396827
25. KD MacDermot A Holmes AH Miners 2001 Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females J Med Genet 38 769 775 10.1136/jmg.38.11.769 1:STN:280:DC%2BD3MnosFyisw%3D%3D 11732485 (Pubitemid 33032933)
26. G Machill G Barbujani GA Danieli, et al. 1991 Segregation and sporadic cases in families with Hunter's syndrome J Med Genet 28 398 401 10.1136/jmg.28.6.398 1:STN:280:DyaK3Mzjt1ymtQ%3D%3D 1908009
27. EM Maier S Osterrieder C Whybra, et al. 2006 Disease manifestations and X inactivation in heterozygous females with Fabry disease Acta Paediatr Suppl 95 30 38 10.1080/08035320600618809 16720462 (Pubitemid 43739092)
28. A Mehta R Ricci U Widmer, et al. 2004 Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey Eur J Clin Invest 34 236 242 10.1111/j.1365-2362.2004.01309.x 1:STN:280: DC%2BD2c7jtlOmtQ%3D%3D 15025684 (Pubitemid 38406640)
29. PJ Meikle JJ Hopwood AE Clague, et al. 1999 Prevalence of lysosomal storage disorders JAMA 281 249 254 10.1001/jama.281.3.249 1:STN:280: DyaK1M7hsFSguw%3D%3D 9918480 (Pubitemid 29058114)
30. JS Mossman S Blunt R Stephens, et al. 1983 Hunter's disease in a girl: association with X:5 chromosomal translocation disrupting the Hunter gene Arch Dis Child 58 911 915 10.1136/adc.58.11.911 1:STN:280:DyaL2c%2FnvVGqug%3D%3D 6418082
31. J Nelson 1997 Incidence of mucopolysaccharidoses in Northern Ireland Hum Genet 101 355 358 10.1007/s004390050641 1:STN:280:DyaK1c7gt1ynsg%3D%3D 9439667 (Pubitemid 28197533)
32. J Nelson J Crowhurst B Carey, et al. 2003 Incidence of the mucopolysaccharidoses in Western Australia Am J Med Genet 123A 310 313 10.1002/ajmg.a.20314 14608657
33. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. 7th edn. McGraw-Hill, New York, pp 1191-1211
34. EF Neufeld I Liebaers CJ Epstein, et al. 1977 The Hunter syndrome in females: is there an autosomal recessive form of iduronate sulphatase deficiency? Am J Hum Genet 29 455 461 1:STN:280:DyaE2s3msVSquw%3D%3D 409284
35. N Nwokoro E Neufeld 1979 Detection of Hunter heterozygotes by enzymatic analysis of hair roots Am J Hum Genet 31 42 49 1:CAS:528:DyaE1MXktVensr4%3D 107796
36. BJHM Poorthuis RA Wevers WJ Kleijer, et al. 1999 The frequency of lysosomal storage diseases in The Netherlands Hum Genet 105 151 156 1:STN:280:DyaK1MvgvVantQ%3D%3D 10480370
37. T Schaap G Bach 1980 Incidence of mucopolysaccharidoses in Israel: is Hunter disease a "Jewish disease"? Hum Genet 56 221 223 10.1007/BF00295699 1:STN:280:DyaL3M%2Fpt1Cqtw%3D%3D 6821579
38. IV Schwartz MG Ribeiro JG Mota, et al. 2007 A clinical study of 77 patients with mucopolysaccharidoses type II Acta Paediatr 96 S 63 70
39. K Sukegawa X-Q Song M Masuno, et al. 1997 Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele Hum Mutat 10 361 367 10.1002/(SICI)1098-1004(1997)10:5<361::AID-HUMU5>3.0.CO;2-I 1:CAS:528:DyaK2sXntlKjsLc%3D 9375851 (Pubitemid 27473296)
40. K Sukegawa T Matsuzaki S Fukuda, et al. 1998 Brother/sister siblings affected with Hunter disease: evidence for skewed X chromosome inactivation Clin Genet 53 96 101 1:STN:280:DyaK1c3nt1Khtg%3D%3D 9611068
41. T Tonnesen 1984 The use of fructose 1-phosphate to detect Hunter heterozygotes in fibroblast cultures from high-risk carriers Hum Genet 66 212 216 10.1007/BF00286603 1:STN:280:DyaL2c7osVegsQ%3D%3D 6425196
42. T Tonnesen C Lykkelund F Güttler 1982 Diagnosis of Hunter's syndrome carriers; radioactive sulphate incorporation into fibroblasts in the presence of fructose 1-phosphate Hum Genet 60 167 171 10.1007/BF00569706 1:STN:280:DyaL387ovVGlsQ%3D%3D 6210620
43. K Tuschl A Gal E Paschke, et al. 2005 Mucopolysaccharidosis type II in females: case report and review of literature Pediatr Neurol 32 270 272 10.1016/j.pediatrneurol.2004.10.009 15797184 (Pubitemid 40410650)
44. YV Voznyi JIM Keulemans OP van Diggelen 2001 A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease) J Inherit Metab Dis 24 675 680 10.1023/A:1012763026526 1:CAS:528:DC%2BD38XltVSisA%3D%3D 11768586 (Pubitemid 33130088)
45. RY Wang A Lelis J Mirocha WR Wilcox 2007 Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life Genet Med 9 34 45 1:CAS:528:DC%2BD2sXlt1eit7Y%3D 17224688
46. Whitley CB (1993) The mucopolysaccharidoses. In: Beighton P (ed) McKusick's heritable disorders of connective tissue. Mosby, St Louis, 367-499
47. C Whybra C Kampmann I Willers, et al. 2001 Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes J Inherit Metab Dis 24 715 724 10.1023/A:1012993305223 1:CAS:528:DC%2BD38XhtV2ktLo%3D 11804208 (Pubitemid 34023880)
48. C Whybra K Wendrich M Ries, et al. 2001 Clinical manifestation in female Fabry disease patients Contrib Nephrol 136 245 250 10.1159/000060196 11688388
49. Willard H (2001) The sex chromosomes and X chromosome inactivation. In: In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1191-1211
50. B Winchester E Young S Geddes, et al. 1992 Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinning Am J Med Genet 44 834 638 10.1002/ajmg.1320440625 1:STN:280: DyaK3s7ivVensw%3D%3D 1481858 (Pubitemid 23006121)
51. ID Young PS Harper 1982 Incidence of Hunter's syndrome Hum Genet 60 391 392 10.1007/BF00569230 1:STN:280:DyaL383mtlKhsQ%3D%3D 6809596
52. J Zlogotora G Bach 1984 Heterozygote detection in Hunter syndrome Am J Med Genet 17 661 665 10.1002/ajmg.1320170317 (Pubitemid 14156981)